tert-Butyl 3-(benzylamino)azetidine-1-carboxylate

Catalog No. :
ACEARS530
CAS No. :
939760-33-5
Molecular Formula :
C15H22N2O2
Molecular Weight :
262.35

IUPAC Name:tert-butyl 3-(benzylamino)azetidine-1-carboxylate

tert-Butyl 3-(benzylamino)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$397.00Login to see priceInquiryInquiry
250mg95%$547.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(benzylamino)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(benzylamino)azetidine-1-carboxylate
MDL No.MFCD08544498
Molecular FormulaC15H22N2O2
Molecular Weight262.35
SMILESO=C(N1CC(NCC2=CC=CC=C2)C1)OC(C)(C)C
InChI KeyZAAOSMHEKVAPLQ-UHFFFAOYSA-N
Synonymtert-butyl 3-(benzylamino)azetidine-1-carboxylate;3-[(Phenylmethyl)amino]-1-azetidinecarboxylic acid tert-butyl ester;tert-butyl 3-(benzylamino)azetidine-1-carboxylate hydrochloride;1-Azetidinecarboxylic acid, 3-[(phenylmethyl)amino]-, 1,1-dimethylethyl ester
CAS No.939760-33-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACEARS530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQFJ674 route compound structure diagram
    ACRQFJ674193269-78-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEARS530 route product structure diagram
    ACEARS530939760-33-5
Inquiry

2. ACEARS530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACEARS530 route product structure diagram
    ACEARS530939760-33-5
Inquiry

Comments (0)